Insight

Karima Oualla: IBCG- AUA Bladder Cancer Forum

Photo taken from Karima Oualla/LinkedIn

May 12, 2024, 00:24

Karima Oualla: IBCG- AUA Bladder Cancer Forum

Karima Oualla, Professor of Medical Oncology at

“I had the privilege to participate to the IBCG- AUA Bladder Cancer Forum at the American Urological Association and debate with my dear Shilpa Gupta on the new standards in 1st line treatment for advanced bladder cancer.

Enfortumab vedotin and Pembrolizumab versus platinum based regimen.

But also catching up with friends in beautiful Texas.”

Karima Oualla

Source: Karima Oualla/LinkedIn

American Urological Association bladder cancer cancer Enfortumab vedotin Hassan II University Hospital IBCG- AUA Bladder Cancer Forum Karima Oualla OncoDaily Oncology pembrolizumab Shilpa Gupta

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage